It has a lot to claw back in terms of share price.
I think it will , steady and slow.
Next catalyst would be FDA CVM update. This could be a huge one.
In the mean time, we may a get a surprise approval for some states in US where Cannabis legislation is not that strict.
Just my thoughts. DYOR
- Forums
- ASX - By Stock
- Ann: June 2021 Quarterly Activities and Cashflow Reports
It has a lot to claw back in terms of share price. I think it...
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AC8 (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.62M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AC8 (ASX) Chart |
Day chart unavailable